COVID-19 mass vaccination – an illustration of the impact of syringe choice on the effectiveness of mass vaccination campaigns

ABSTRACT

In order to optimise the operational implementation of mass vaccination policies, it is critical to consider not only the supply of vaccines as well as each element of the vaccination process. This study, which was conducted in a vaccination center clearly shows how the choice of a syringe reference used during the COVID-19 vaccination campaign influences the number of vaccine doses available. The results appear to be closely related to the type of vaccine used (COMIRNATY® and SPIKEVAX®). In this context, the choice of the right reference of syringe has major economic and organisational consequences on a global scale.

KEYWORDS:

• Mass vaccination
• COVID-19
• medical device
• public health
• vaccination capacity

Acknowledgements

Mazet Roseline (Wrote Manuscript/Designed Research/Performed Research), Choisnard Luc (Wrote Manuscript/Designed Research/Analyzed Data), Epaulard Olivier (Designed Research), Leenhardt Julien (Designed Research), Brudieu Etienne (Designed Research) and Bedouch Pierrick (Designed Research). Special thanks to Vanessa FAUCHERAND for her English proofreading.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Correction Statement

This article has been corrected with minor changes. These changes do not impact the academic content of the article.

Additional information

Funding

We acknowledge support from LabEx ARCANE and CBH-EUR-GS [grant number #ANR-17-EURE-0003] and the Glyco@Alps programme [grant #ANR-15-IDEX-02]. DPM are part of Institut Carnot PolyNat [grant #ANR-11-CARN-030-01]; Agence Nationale de la Recherche.